Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia
Completed
Conditions studied: Sickle Cell Disease, Renal Disease, Glomerular Disease
In brief
The investigators will attempt to develop a more accurate equation to estimate eGFR in pediatric and adult sickle cell patients
Key facts
- Study ID
- NCT04380610
- Run by
- University of Alabama at Birmingham
- People needed
- 120
- Starts
- 2021-05-12
- Expected to finish
- 2025-06-30
- Last updated by the study team
- 2025-09-18
Who can join
Age: 5 and older, up to 50. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- SCA patients (HbSS and SB0 thalassemia)
- Age: 5.0-50.0 at enrollment
You may not qualify if…
- Recent SCA complication associated with hospitalization (within 30 days) or ED visit (within 14 days)
- Current AKI defined as >0.3mg/g increase in SCr from prior visit
- Known history of anaphylaxis with contrast agent or known pregnancy
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
- University of Illinois Chicage — Chicago, Illinois, United States
- St Jude Childrens Research Hospital — Memphis, Tennessee, United States
- University of Tennessee Health Science Center — Memphis, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.